Protocol Ledger

NCT04114981 · Phase III · ACTIVE NOT RECRUITING

Single Fraction Stereotactic Radiosurgery or Three to Five Fraction Stereotactic Radiosurgery in Treating Patients With Brain Metastasis That Has Been Removed by Surgery

Interventional Phase III clinical trial protocol NCT04114981 sponsored by Alliance for Clinical Trials in Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-11-19 Enrollment: 242 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04114981
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)242 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04114981
Protocol FieldVerified Registry Value
NCT IdentifierNCT04114981
Consolidated Lead SponsorAlliance for Clinical Trials in Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment242 participants (ACTUAL)
Registered Start Date2019-11-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI